NasdaqGS:LIVNMedical Equipment
LivaNova (LIVN): Assessing Valuation Following Essenz Perfusion System Launch in China
LivaNova (LIVN) is making headlines this week after announcing the commercial launch of its Essenz Perfusion System in China, following recent local regulatory approval. For investors, this move represents more than just a product expansion, as it positions LivaNova to enter the world’s second-largest market for heart-lung machines. With China’s extensive cardiac surgery needs and a technology-driven system co-developed with clinicians, this milestone could serve as a meaningful catalyst for...